Search details
1.
The Epigenetic Reader Protein SP140 Regulates Dendritic Cell Activation, Maturation and Tolerogenic Potential.
Curr Issues Mol Biol
; 45(5): 4228-4245, 2023 May 11.
Article
in English
| MEDLINE | ID: mdl-37232738
2.
In silico enhancer mining reveals SNS-032 and EHMT2 inhibitors as therapeutic candidates in high-grade serous ovarian cancer.
Br J Cancer
; 129(1): 163-174, 2023 07.
Article
in English
| MEDLINE | ID: mdl-37120667
3.
Modulation of macrophage inflammatory function through selective inhibition of the epigenetic reader protein SP140.
BMC Biol
; 20(1): 182, 2022 08 19.
Article
in English
| MEDLINE | ID: mdl-35986286
4.
Potent antimyeloma activity of the novel bromodomain inhibitors I-BET151 and I-BET762.
Blood
; 123(5): 697-705, 2014 Jan 30.
Article
in English
| MEDLINE | ID: mdl-24335499
5.
Bromodomain inhibitor i-BET858 triggers a unique transcriptional response coupled to enhanced DNA damage, cell cycle arrest and apoptosis in high-grade ovarian carcinoma cells.
Clin Epigenetics
; 15(1): 63, 2023 04 15.
Article
in English
| MEDLINE | ID: mdl-37060086
6.
Selective Targeting of Epigenetic Readers and Histone Deacetylases in Autoimmune and Inflammatory Diseases: Recent Advances and Future Perspectives.
J Pers Med
; 11(5)2021 Apr 23.
Article
in English
| MEDLINE | ID: mdl-33922725
7.
HDAC3 Mediates the Inflammatory Response and LPS Tolerance in Human Monocytes and Macrophages.
Front Immunol
; 11: 550769, 2020.
Article
in English
| MEDLINE | ID: mdl-33123128
8.
Selective targeting of BD1 and BD2 of the BET proteins in cancer and immunoinflammation.
Science
; 368(6489): 387-394, 2020 04 24.
Article
in English
| MEDLINE | ID: mdl-32193360
Results
1 -
8
de 8
1
Next >
>>